Log in

NASDAQ:REYN - Black Diamond Therapeutics Stock Price, Forecast & News

$29.98
-0.11 (-0.37 %)
(As of 02/27/2020 03:40 AM ET)
Today's Range
$29.78
Now: $29.98
$30.56
50-Day Range N/A
52-Week Range
$27.10
Now: $29.98
$31.99
Volume539,050 shs
Average Volume1.08 million shs
Market Capitalization$6.07 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Reynolds Consumer Products Inc., a consumer products company, produces and sells products across cooking, waste and storage, and tableware. It operates through four segments: Reynolds Cooking & Baking, Hefty Waste & Storage, Hefty Tableware, and Presto Products. The Reynolds Cooking & Baking segment produce foil, parchment paper, and disposable aluminum pans, as well as cooker liners. The company sells its products under the Reynolds Wrap, Reynolds KITCHENS, E-Z Foil, Diamond, and ALCAN brands in the United States, Canada, and internationally. The Hefty Waste & Storage segment produce trash and food storage bags under the brand names, such as Hefty Ultra Strong, Hefty Strong Trash Bags, and Hefty Slider Bags. The Hefty Tableware segment sells disposable plates, bowls, platters, cups, and cutlery. This segment's branded products include dishes and party cups under the Hefty brand. The Presto Products segment primarily sell food storage bags, trash bags, disposable storage containers, and plastic wraps. The company was founded in 1947 and is headquartered in Lake Forest, Illinois.

Industry, Sector and Symbol

Industry Bags: plastic, laminated, & coated
Sub-IndustryN/A
SectorConsumer Discretionary
Current SymbolNASDAQ:REYN
CUSIPN/A
CIKN/A
Phone800-879-5067

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees5,000
Market Cap$6.07 billion
Next Earnings Date3/10/2020 (Confirmed)
OptionableOptionable

Receive REYN News and Ratings via Email

Sign-up to receive the latest news and ratings for REYN and its competitors with MarketBeat's FREE daily newsletter.


Black Diamond Therapeutics (NASDAQ:REYN) Frequently Asked Questions

What is Black Diamond Therapeutics' stock symbol?

Black Diamond Therapeutics trades on the NASDAQ under the ticker symbol "REYN."

When is Black Diamond Therapeutics' next earnings date?

Black Diamond Therapeutics is scheduled to release their next quarterly earnings announcement on Tuesday, March 10th 2020. View Earnings Estimates for Black Diamond Therapeutics.

How can I listen to Black Diamond Therapeutics' earnings call?

Black Diamond Therapeutics will be holding an earnings conference call on Tuesday, March 10th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What price target have analysts set for REYN?

9 brokerages have issued 12-month target prices for Black Diamond Therapeutics' shares. Their forecasts range from $31.00 to $40.00. On average, they anticipate Black Diamond Therapeutics' share price to reach $35.22 in the next year. This suggests a possible upside of 17.5% from the stock's current price. View Analyst Price Targets for Black Diamond Therapeutics.

What is the consensus analysts' recommendation for Black Diamond Therapeutics?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Black Diamond Therapeutics in the last year. There are currently 2 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Black Diamond Therapeutics.

Has Black Diamond Therapeutics been receiving favorable news coverage?

Headlines about REYN stock have trended negative this week, InfoTrie Sentiment reports. The research group scores the sentiment of news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Black Diamond Therapeutics earned a media sentiment score of -2.1 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the near future. View News Stories for Black Diamond Therapeutics.

Who are some of Black Diamond Therapeutics' key competitors?

What other stocks do shareholders of Black Diamond Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Black Diamond Therapeutics investors own include GW Pharmaceuticals PLC- (GWPH), Fortinet (FTNT), Freshpet (FRPT), Five9 (FIVN), Etsy (ETSY), Equinix (EQIX), Editas Medicine (EDIT), Docusign (DOCU), Cypress Semiconductor (CY) and Crispr Therapeutics (CRSP).

Who are Black Diamond Therapeutics' key executives?

Black Diamond Therapeutics' management team includes the folowing people:
  • Mr. Lance Mitchell, CEO, Pres & Director (Age 60)
  • Mr. Michael Graham, Chief Financial Officer (Age 57)
  • Mr. Stephan M. Pace, Pres of Walmart/Sam's and eCommerce (Age 57)
  • Mr. Craig Cappel, Pres of Reynolds Cooking & Baking (Age 49)
  • Mr. David Watson, Gen. Counsel

When did Black Diamond Therapeutics IPO?

(REYN) raised $1.3 billion in an initial public offering on Friday, January 31st 2020. The company issued 47,200,000 shares at $25.00-$28.00 per share. Credit Suisse, Goldman Sachs and J.P. Morgan served as the underwriters for the IPO and Barclays, Citigroup, Evercore ISI, RBC Capital Markets, HSBC, Stifel, SunTrust Robinson Humphrey and Academy Securities were co-managers.

When does the company's quiet period expire?

Black Diamond Therapeutics' quiet period expires on Wednesday, March 11th. Black Diamond Therapeutics had issued 47,170,000 shares in its public offering on January 31st. The total size of the offering was $1,226,420,000 based on an initial share price of $26.00. During the company's quiet period, underwriters and any insiders involved in the IPO are restricted from issuing any earnings forecasts or research reports for the company because of SEC regulations. Following the end of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

How do I buy shares of Black Diamond Therapeutics?

Shares of REYN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Black Diamond Therapeutics' stock price today?

One share of REYN stock can currently be purchased for approximately $29.98.

How big of a company is Black Diamond Therapeutics?

Black Diamond Therapeutics has a market capitalization of $6.07 billion. Black Diamond Therapeutics employs 5,000 workers across the globe.View Additional Information About Black Diamond Therapeutics.

What is Black Diamond Therapeutics' official website?

The official website for Black Diamond Therapeutics is http://www.reynoldsconsumerproducts.com/.

How can I contact Black Diamond Therapeutics?

Black Diamond Therapeutics' mailing address is 1900 W. FIELD COURT, LAKE FOREST IL, 60045. The company can be reached via phone at 800-879-5067 or via email at [email protected]


MarketBeat Community Rating for Black Diamond Therapeutics (NASDAQ REYN)

Community Ranking:  3.7 out of 5 (star star star)
Outperform Votes:  11 (Vote Outperform)
Underperform Votes:  4 (Vote Underperform)
Total Votes:  15
MarketBeat's community ratings are surveys of what our community members think about Black Diamond Therapeutics and other stocks. Vote "Outperform" if you believe REYN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe REYN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/27/2020 by MarketBeat.com Staff

Featured Article: Monthly Dividend Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel